Cite
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
MLA
Johnson, Philip J., et al. “Evaluation of the AMAP Score for Hepatocellular Carcinoma Surveillance: A Realistic Opportunity to Risk Stratify.” British Journal of Cancer, vol. 127, no. 7, Oct. 2022, pp. 1263–69. EBSCOhost, https://doi.org/10.1038/s41416-022-01851-1.
APA
Johnson, P. J., Innes, H., Hughes, D. M., Kalyuzhnyy, A., Kumada, T., & Toyoda, H. (2022). Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify. British Journal of Cancer, 127(7), 1263–1269. https://doi.org/10.1038/s41416-022-01851-1
Chicago
Johnson, Philip J., Hamish Innes, David M. Hughes, Anton Kalyuzhnyy, Takashi Kumada, and Hidenori Toyoda. 2022. “Evaluation of the AMAP Score for Hepatocellular Carcinoma Surveillance: A Realistic Opportunity to Risk Stratify.” British Journal of Cancer 127 (7): 1263–69. doi:10.1038/s41416-022-01851-1.